GENZ - Genzyme Corporation

Your Recent Quotes: 0 | 0
Price Glossary Definition
61.21 -2.35
-3.70%
12/04/08 4:00
Open
62.53
Prev Close
63.56
Volume
2,981,727
52 Wk. Range
57.61- 83.97
Year-to-Date Performance Glossary Definition
DOWN -14.62%
Latest Dividend for GENZ
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
38.74
 
40.60
 
14.30
GENZ
Sect. Av.
S&P 500
Market Cap
16,242,020,800
Outstanding Shares
266,883,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy GENZ Rating Report
Rating History for GENZ
Target Price (1Yr)
High
102.00
Revenue
4.67B

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
19.70
0.73
0.20
Net Income
N/A
4.55
0.76
EPS
N/A
3.79
0.68

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-18.74
-13.52
-14.90
Earnings Per Share($)

12/2005
 
 
 
1.73
12/2006
 
 
 
-0.06
12/2007
 
 
 
1.82

Earnings for GENZ
EBITDA
1.10B
Revenue
3.81B
Outside Analyst Rating History

12/4/08
13
Buy
12/4/08
2
Hold
12/4/08
0
Sell

Jim Cramer Portfolio
Find out now if GENZ is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Latest GENZ Headlines
Here's what Cramer's had to say recently about Goldman Sachs.

1:04PM 12/03/08

Staff members look at analysts' upgrades and downgrades and Laurie Kulikowski talks about Citi's purchase of a Spanish road operator after its government bailout.

10:39AM 12/03/08

See who made what calls.

10:06AM 12/03/08

Cramer says it's become one of the worst natural gas companies.

7:57PM 12/01/08

These stocks are in growing fields -- you can buy and sleep easy.

10:12AM 11/25/08

Health care reform is expected to be a top priority for the Obama administration. These are some potential changes investors in managed-care, pharma and biotech stocks should bear in mind.

2:09PM 11/19/08

Stephanie Link, director of research for the Action Alerts PLUS Portfolio, unveils the shocker stock of the week and explains why it's safe even without a dividend.

08:59PM 11/16/08

Video
Alaska Air and Genzyme are upgraded; Berkshire Hathaway and Valhi are downgraded.

5:38PM 11/14/08

The FDA is inclined to approve ferumoxytol (an injectable iron replacement therapy to treat anemia in patients with chronic kidney disease).

1:44PM 11/13/08

Stephanie Link, director of research for the Action Alerts Plus Portfolio, unveils the shocker stock of the week and explains why it's safe even without a dividend.

05:32PM 11/12/08

Video
Understanding the Market

Our Experts' Take at RealMoney for Genzyme Corporation
As long as unemployment doesn't skyrocket, this market is a buy on weakness.

12:04PM 12/04/08

I've picked out a few items from the maelstrom of recent data.

11:07AM 12/04/08

More Experts' Takes on GENZ


Premium Stock Ideas
Is Cramer trading GENZ in his Action Alerts Plus Portfolio?

Premium Services